Compare
Assurant, Inc. vs Renaissancere Holdings Ltd vs Unum Group vs Oscar Health, Inc.
| Latest fiscal year | Assurant, Inc. AIZ | Renaissancere Holdings Ltd RNR | Unum Group UNM | Oscar Health, Inc. OSCR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $12.81B | $12.85B | $13.08B | $11.70B |
| Revenue growth (YoY) | +7.9% | +9.9% | +1.5% | +27.5% |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | -3.4% |
| Net margin | 6.8% | 20.9% | 5.6% | -3.8% |
| Net income | $872.70M | $2.68B | $738.50M | -$443.15M |
| EPS (Diluted) | $16.93 | $56.03 | $4.27 | -$1.69 |
| Operating cash flow | $1.83B | $3.69B | $687.70M | $1.09B |
| Free cash flow | $1.60B | n/a | $555.40M | $1.06B |
| Cash & equivalents | $1.83B | $1.73B | n/a | $2.77B |
| Total assets | $36.29B | $53.80B | $63.52B | $6.33B |
| Total liabilities | $30.42B | $34.59B | $52.40B | $5.34B |
| Shareholders' equity | $5.87B | $11.61B | $11.12B | $980.74M |
| Return on year-end equity | 14.9% | 23.1% | 6.6% | -45.2% |
| Shares outstanding | 49.79M | 43.96M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Assurant, Inc. | Renaissancere Holdings Ltd | Unum Group | Oscar Health, Inc. |
|---|---|---|---|---|
| Latest | $12.81B Ended 2025-12-31 | $12.85B Ended 2025-12-31 | $13.08B Ended 2025-12-31 | $11.70B Ended 2025-12-31 |
| 1 year earlier | $11.88B Ended 2024-12-31 | $11.70B Ended 2024-12-31 | $12.89B Ended 2024-12-31 | $9.18B Ended 2024-12-31 |
| 2 years earlier | $11.13B Ended 2023-12-31 | $9.13B Ended 2023-12-31 | $12.39B Ended 2023-12-31 | $5.86B Ended 2023-12-31 |
| 3 years earlier | $10.19B Ended 2022-12-31 | $5.06B Ended 2022-12-31 | $11.98B Ended 2022-12-31 | $3.96B Ended 2022-12-31 |
| 4 years earlier | $10.19B Ended 2021-12-31 | $5.28B Ended 2021-12-31 | $12.01B Ended 2021-12-31 | $1.84B Ended 2021-12-31 |